Condition: Tobacco Use Disorder · Sponsor: University of Missouri-Columbia
This research study is looking into the effects of clavulanic on smoking behavior in adult cigarette smokers. The primary study hypothesis is that, compared to placebo, clavulanic acid will reduce smoking over the course of the study.
This description comes directly from the study's public registry record.
Madhura Athreya, MS · 573-882-2977 · athreyam@health.missouri.edu
Brett E Froeliger, PhD · 573-882-4785 · froeligerb@health.missouri.edu
Always discuss trial participation with your own doctor first.
| University of Missouri - Columbia | Columbia, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03713424